← Eichor
Study identifier: NCT06565520 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain

Condition: Patellofemoral Pain Syndrome  ·  Sponsor: University of Nevada, Las Vegas

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.

This description comes directly from the study's public registry record.

Talk to the study team

Kai Yu Ho, PhD  ·  7028952629  ·  kaiyu.ho@unlv.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Nevada, Las VegasLas Vegas, Nevada, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06565520